158 related articles for article (PubMed ID: 32439311)
1. Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directions.
Ponnusamy L; Natarajan SR; Thangaraj K; Manoharan R
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188379. PubMed ID: 32439311
[TBL] [Abstract][Full Text] [Related]
2. AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer.
Cao W; Li J; Hao Q; Vadgama JV; Wu Y
Breast Cancer Res; 2019 Feb; 21(1):29. PubMed ID: 30791936
[TBL] [Abstract][Full Text] [Related]
3. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
[TBL] [Abstract][Full Text] [Related]
4. Selective AMPK activator leads to unfolded protein response downregulation and induces breast cancer cell death and autophagy.
Nascimento Mello AL; Sagrillo FS; de Souza AG; Costa ARP; Campos VR; Cunha AC; Imbroisi Filho R; da Costa Santos Boechat F; Sola-Penna M; de Souza MCBV; Zancan P
Life Sci; 2021 Jul; 276():119470. PubMed ID: 33831423
[TBL] [Abstract][Full Text] [Related]
5. AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity.
Zou YF; Xie CW; Yang SX; Xiong JP
Mol Med Rep; 2017 Feb; 15(2):899-907. PubMed ID: 28035400
[TBL] [Abstract][Full Text] [Related]
6. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
7. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
[TBL] [Abstract][Full Text] [Related]
8. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
[TBL] [Abstract][Full Text] [Related]
9. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
10. Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities.
Vazirian M; Nabavi SM; Jafari S; Manayi A
Food Chem Toxicol; 2018 Dec; 122():69-79. PubMed ID: 30290216
[TBL] [Abstract][Full Text] [Related]
11. ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.
Chung SJ; Nagaraju GP; Nagalingam A; Muniraj N; Kuppusamy P; Walker A; Woo J; Győrffy B; Gabrielson E; Saxena NK; Sharma D
Autophagy; 2017 Aug; 13(8):1386-1403. PubMed ID: 28696138
[TBL] [Abstract][Full Text] [Related]
12. Acetylsalicylic Acid Governs the Effect of Sorafenib in
Hammerlindl H; Ravindran Menon D; Hammerlindl S; Emran AA; Torrano J; Sproesser K; Thakkar D; Xiao M; Atkinson VG; Gabrielli B; Haass NK; Herlyn M; Krepler C; Schaider H
Clin Cancer Res; 2018 Mar; 24(5):1090-1102. PubMed ID: 29196297
[No Abstract] [Full Text] [Related]
13. Promise and challenges for direct small molecule AMPK activators.
Olivier S; Foretz M; Viollet B
Biochem Pharmacol; 2018 Jul; 153():147-158. PubMed ID: 29408352
[TBL] [Abstract][Full Text] [Related]
14. Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics.
Arkwright RT; Deshmukh R; Adapa N; Stevens R; Zonder E; Zhang Z; Farshi P; Ahmed RS; El-Banna HA; Chan TH; Dou QP
Anticancer Agents Med Chem; 2015; 15(5):657-71. PubMed ID: 25511514
[TBL] [Abstract][Full Text] [Related]
15. Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome.
Hill JL; Kobori N; Zhao J; Rozas NS; Hylin MJ; Moore AN; Dash PK
J Neurochem; 2016 Oct; 139(1):106-19. PubMed ID: 27379837
[TBL] [Abstract][Full Text] [Related]
16. 5'-AMP-activated protein kinase (AMPK) regulates progesterone receptor transcriptional activity in breast cancer cells.
Wu L; Huang XJ; Yang CH; Deng SS; Qian M; Zang Y; Li J
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):172-7. PubMed ID: 22093824
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
[TBL] [Abstract][Full Text] [Related]
19. Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells.
Shieh JM; Chen YC; Lin YC; Lin JN; Chen WC; Chen YY; Ho CT; Way TD
J Agric Food Chem; 2013 Jul; 61(26):6366-75. PubMed ID: 23777448
[TBL] [Abstract][Full Text] [Related]
20. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK
PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
